Skip to main content
. 2021 Mar 11;11:639947. doi: 10.3389/fonc.2021.639947

Figure 5.

Figure 5

The comparison of traditional chemotherapy versus combined immunotherapy in second line treatment. The PFS, OS and ORR of traditional chemotherapy and combined immunotherapy in second line treatment among the whole cohorts (A), cohort with TKI-PFS < 10 months (B), and cohort with TKI-PFS > 10 months (C). ns, none sense.